Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
Loading CBIO News...
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 0.91% | 73.38 | 0.9% | $725.47m | |
| AMGN | Amgen Inc. | 0.75% | 180.52 | 1.1% | $595.42m | |
| CELG | Celgene Corporation | 1.37% | 136.85 | 1.1% | $589.74m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.73% | 520.63 | 2.7% | $544.84m | |
| BIIB | Biogen Inc. | 0.70% | 283.92 | 1.2% | $408.27m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.03% | 159.64 | 1.9% | $370.01m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.77% | 129.55 | 1.9% | $285.53m | |
| CLVS | Clovis Oncology, Inc. | 4.08% | 87.27 | 18.0% | $176.00m | |
| TSRO | TESARO, Inc. | 3.37% | 128.20 | 14.7% | $169.77m | |
| INCY | Incyte Corporation | 1.81% | 132.81 | 2.6% | $169.51m | |
| ILMN | Illumina, Inc. | -0.34% | 173.29 | 3.5% | $159.29m | |
| EXEL | Exelixis, Inc. | 2.09% | 27.31 | 6.5% | $156.56m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.62% | 87.77 | 4.4% | $131.86m | |
| KITE | Kite Pharma, Inc. | 2.36% | 107.92 | 16.1% | $122.46m | |
| BLUE | Bluebird Bio, Inc. | 0.62% | 97.90 | 19.3% | $118.03m |
Company Profile
Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel medicines to address hematology indications. It offers next generation hemostasis programs and anti-complement assets. The company was founded on August 5, 2002 and is headquartered in South San Francisco, CA.